论文信息 - A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies. - 字舞流文

A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies.

K. Heider | S. Stilgenbauer | G. Adolf | T. Zenz | A. Baum | E. Ostermann | S. Müller | H. Lamche | Kerstin Kiefer | M. Volden | Z. Kuepcue | A. Jacobi | U. Hirt | E. Borges | Z. Küpcü | S. Müller